MTR polymorphic variant A2756G and retinoblastoma risk in brazilian children

Pediatric Blood and Cancer

Volumn 54, Issue 7, 2010, Pages 904-908

  De Lima, Elker Lene Santos ^a,b   Da Silva, Vanessa Cavalcante ^a   Da Silva, Hildson Dornelas Angelo ^a   Bezerra, Alexandre Medeiros ^a   De Morais, Vera Lucia Lins ^a   De Morais, Adriana Lins ^a   Cruz, Raquel Vera ^a   Barros, Mário Henrique Magalhães ^c   Hassan, Rocio ^c   De Freitas, Antonio Carlos ^d   Muniz, Maria Tereza Cartaxo ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSIDADE DE PERNAMBUCO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Brazilian population; MTHFR C677T and A1298C; MTR A2756G; Retinoblastoma; RFC A80G; TYMS

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE;

ALLELE; ARTICLE; BRAZIL; CANCER RISK; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; SCHOOL CHILD; WILD TYPE;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; REPLICATION PROTEIN C; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK FACTORS; THYMIDYLATE SYNTHASE;

EID: 77951763539     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22472     Document Type: Article

References (34)

1. Choy KW, Pang CP, Yu CBO, et al. Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma. Hum Mutat 2002;20:408-416.
2. Friend S, Bernads R, Rojelj R, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646. (Pubitemid 16008560)
3. Stiller C, Parkin D. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996;52:682-703. (Pubitemid 27007679)
4. Orjuela MA, Liu LTX, Ramirez-Ortiz M, et al. Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev 2005;14:1433-1440. (Pubitemid 40807342)
5. Sharrard RM, Royds JA, Rogers S, et al. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 1992;65:667-672.
6. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-540. (Pubitemid 24308343)
7. Hiltunen MO, Alhonen L, Koistinaho J, et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 1997;70:644-648. (Pubitemid 27158441)
8. Niclot S, Pruvot Q, Besson C, et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 2006;108:278-285. (Pubitemid 43990639)
9. Ulvik A, Vollset SE, Hansen S, et al. Colorectal cancer and the methylenetetrahydrofolate reductase 677C→T and methionine synthase 2756A→G polymorphisms: A study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004;13:2175-2180. (Pubitemid 40054314)
10. Bailey LB, Gregory JF III. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919-922.
11. Mokarram P, Naghibalhossaini F, Firoozi MS, et al. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroenterol 2008;14:3662-3671.
12. Datta S, Koutmos M, Pattridge KA, et al. A disulfide-stabilized conformer of methionine synthase reveals an unexpected role for the histidine ligand of the cobalamin cofactor. Proc Natl Acad Sci USA 2008;105:4115-4120. (Pubitemid 351754342)
13. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004;159:423-443. (Pubitemid 38280289)
14. Stern LL, Mason JB, Selhub J, et al. Genomic DNA hypomethylation: A characteristic of most cancers is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in theMTHFR gene. Cancer Epidemiol Biomarkers Prev 2000;9:849-853. (Pubitemid 30660060)
15. Kaneda S, Takeishi K, Ayusawa D. et al. Role in translation of a triple tandemly repeated sequence in the 5-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res 1987;15:1259-1270. (Pubitemid 17012904)
16. Kawakami K, Omura K, Kanehira E, et al. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 1999;19:3249-3252. (Pubitemid 30042617)
17. Ulrich CM, Curtin K, Potter JD, et al. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2509-2516. (Pubitemid 41752708)
18. Chango A, Emery-Fillon N, De Courcy GP, et al. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310-315.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989. pp 9.14-9.19.
20. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: A review. J Nutr 2002;132:2350S-2355S. (Pubitemid 35340338)
21. Heijmans BT, Boer JM, Suchiman HE, et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 2003;63:1249-1253. (Pubitemid 36348702)
22. Pogribny IP, Muskhelishvili L, Miller BJ, et al. Presence and consequence of uracil in preneoplastic DNA from folate/methyldeficient rats. Carcinogenesis 1997;18:2071-2076. (Pubitemid 28134731)
23. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implication for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295. (Pubitemid 27157304)
24. Zing JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18:869-882.
25. Duthie SJ. Folic acid deficiency and cancer: Mechanisms of DNA instability. Br Med Bull 1999;55:578-592.
26. Guerreiro CS, Carmona B, Gonçalves S, et al. Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. Am J Clin Nutr 2008;88:1413-1418.
27. Götze T, Röcken C, Röhl FW, et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 2007;251:228-236. (Pubitemid 46669797)
28. Yuan JM, Lu SC, Van Den Berg D, et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 2007;46:749-758. (Pubitemid 47436121)
29. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-3791. (Pubitemid 34534552)
30. Skibola CF, Forrest MS, Coppede F, et al. Polymorphisms and haplotypes in folate metabolizing genes and risk of non-Hodgkin's lymphoma. Blood 2005;105:2155-2162. (Pubitemid 43068838)
31. Barlow D. Methylation and imprinting: From host defense to gene regulation? Science 1993;260:309-310.
32. Mancini D, Singh S, Ainsworth P, et al. Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). Am J Hum Genet 1997;61:80-87. (Pubitemid 27323326)
33. Lima CS, Ortega MM, Ozelo MC, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leukemia Res 2008;32:401-405.
34. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in Brazilians. Proc Natl Aacd Sci USA 2003;100:177-182.